BiotechTube

Ospemifene + Placebo

Phase 3Completed
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Vaginal Dryness

Conditions

Vaginal Dryness

Trial Timeline

Jan 26, 2016 → Jul 5, 2017

NCT ID
NCT02638337

About Ospemifene + Placebo

Ospemifene + Placebo is a phase 3 stage product being developed by Shionogi for Vaginal Dryness. The current trial status is completed. This product is registered under clinical trial identifier NCT02638337. Target conditions include Vaginal Dryness.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT02638337Phase 3Completed

Competing Products

19 competing products in Vaginal Dryness

See all competitors
ProductCompanyStageHype Score
Estradiol Vaginal Tablets 10 mcg (Glenmark) + Vagifem® (Estradiol Vaginal Tablets) 10 mcg (Novo Nordisk) + Placebo of Estradiol Vaginal Tablets 10 mcg (Glenmark)Glenmark PharmaceuticalsPhase 3
77
SHR8008 + FluconazoleJiangsu Hengrui MedicinePhase 3
77
SHR8008 capsule + Fluconazole capsuleJiangsu Hengrui MedicinePhase 3
77
PembrolizumabMerckPhase 2
52
Vagifem® + Non-Vagifem® LDVE, EstradiolNovo NordiskPre-clinical
22
Estradiol 10 MCG Vaginal Tablet [VAGIFEM] + Promestriene VaginalNovo NordiskPhase 3
76
FluconazolePfizerPhase 3
76
Bazedoxifene/Conjugated EstrogenPfizerPhase 3
76
CardunolizumabInnovent BiologicsPhase 2
51
Clotrimazole 1% (Empecid L Cream, BAYB5097)BayerPre-clinical
20
Clotrimazole vaginal tablet + FluconazoleBayerApproved
82
Metronidazole/Miconazole (Neo-Penotran Forte, BAY86-5276)BayerPre-clinical
20
Placebo vaginal ringOrganonPhase 3
72
SCY-078 + FluconazoleScynexisPhase 2
44
IbrexafungerpScynexisPhase 3
69
Fluconazole Tablet + IBREXAFUNGERP + Placebo oral tabletScynexisPhase 3
69
IbrexafungerpScynexisPhase 1
25
Estradiol + PlaceboTherapeuticsMDPhase 3
69
Oral Encochleated Amphotericin B (CAMB) + Oral Encochleated Amphotericin B (CAMB)Matinas BiopharmaPhase 2
44

Other Products from Shionogi

Naldemedine + PlaceboApproved
85
Rosuvastatin + HMG CoA inhibitorApproved
85
StatinApproved
85
CefiderocolApproved
85
Duloxetine + Pregabalin + PlaceboApproved
85